Detection of multidrug resistance associated P-170 glycoprotein in previously untreated non small cell lung cancer. 1991

G V Scagliotti, and F Michelotto, and G Kalikatzaros, and E Leonardo, and S Cappia, and L Gubetta, and P Borasio, and E Pozzi
University of Turin, Department of Clinical and Biological Sciences, Italy.

Samples of Non Small Cell Lung Cancer (NSCLC) and normal bronchial tissue obtained in patients submitted to radical surgery and without previous exposure to cytotoxic drugs were investigated for the expression of P-170 glycoprotein using C-219 monoclonal antibody and an immunohistochemistry technique. In normal bronchial tissue the immunostaining was confined to the lumenal surface of the epithelium. Fifteen out of 86 NSCLC had more than 1/4 of examined cells positive for P-170 glycoprotein, but the heterogeneity of the expression ranged from rare scattered cells to a positive pattern for nearly all cells considered, without any relationship with pathologic and clinical prognostic variables.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008297 Male Males
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002289 Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. Carcinoma, Non-Small Cell Lung,Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinoma,Nonsmall Cell Lung Cancer,Carcinoma, Non Small Cell Lung,Carcinomas, Non-Small-Cell Lung,Lung Carcinoma, Non-Small-Cell,Lung Carcinomas, Non-Small-Cell,Non Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinomas
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G V Scagliotti, and F Michelotto, and G Kalikatzaros, and E Leonardo, and S Cappia, and L Gubetta, and P Borasio, and E Pozzi
June 2005, Journal of cancer research and clinical oncology,
G V Scagliotti, and F Michelotto, and G Kalikatzaros, and E Leonardo, and S Cappia, and L Gubetta, and P Borasio, and E Pozzi
May 1998, British journal of cancer,
G V Scagliotti, and F Michelotto, and G Kalikatzaros, and E Leonardo, and S Cappia, and L Gubetta, and P Borasio, and E Pozzi
December 1993, Blood,
G V Scagliotti, and F Michelotto, and G Kalikatzaros, and E Leonardo, and S Cappia, and L Gubetta, and P Borasio, and E Pozzi
January 2005, Lung,
G V Scagliotti, and F Michelotto, and G Kalikatzaros, and E Leonardo, and S Cappia, and L Gubetta, and P Borasio, and E Pozzi
January 1999, Annals of oncology : official journal of the European Society for Medical Oncology,
G V Scagliotti, and F Michelotto, and G Kalikatzaros, and E Leonardo, and S Cappia, and L Gubetta, and P Borasio, and E Pozzi
August 1992, Cancer research,
G V Scagliotti, and F Michelotto, and G Kalikatzaros, and E Leonardo, and S Cappia, and L Gubetta, and P Borasio, and E Pozzi
May 1999, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases,
G V Scagliotti, and F Michelotto, and G Kalikatzaros, and E Leonardo, and S Cappia, and L Gubetta, and P Borasio, and E Pozzi
November 1999, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases,
G V Scagliotti, and F Michelotto, and G Kalikatzaros, and E Leonardo, and S Cappia, and L Gubetta, and P Borasio, and E Pozzi
June 1991, Haematologica,
G V Scagliotti, and F Michelotto, and G Kalikatzaros, and E Leonardo, and S Cappia, and L Gubetta, and P Borasio, and E Pozzi
January 2023, Methods in molecular biology (Clifton, N.J.),
Copied contents to your clipboard!